DK1328269T5 - Kombination af en CB1-receptorantagonist og sibutramin til behandling af fedme - Google Patents
Kombination af en CB1-receptorantagonist og sibutramin til behandling af fedmeInfo
- Publication number
- DK1328269T5 DK1328269T5 DK01974413T DK01974413T DK1328269T5 DK 1328269 T5 DK1328269 T5 DK 1328269T5 DK 01974413 T DK01974413 T DK 01974413T DK 01974413 T DK01974413 T DK 01974413T DK 1328269 T5 DK1328269 T5 DK 1328269T5
- Authority
- DK
- Denmark
- Prior art keywords
- receptor antagonist
- obesity
- sibutramine
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0012646A FR2814678B1 (fr) | 2000-10-04 | 2000-10-04 | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
PCT/FR2001/003022 WO2002028346A2 (fr) | 2000-10-04 | 2001-10-01 | Association d'un antagoniste du recepteur cb1 et de sibutramine, pour le traitement de l'obesite |
Publications (3)
Publication Number | Publication Date |
---|---|
DK1328269T3 DK1328269T3 (da) | 2004-09-20 |
DK1328269T4 DK1328269T4 (da) | 2008-11-24 |
DK1328269T5 true DK1328269T5 (da) | 2009-03-16 |
Family
ID=8854974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01974413T DK1328269T5 (da) | 2000-10-04 | 2001-10-01 | Kombination af en CB1-receptorantagonist og sibutramin til behandling af fedme |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1328269B2 (zh) |
JP (1) | JP4221221B2 (zh) |
KR (1) | KR20030036885A (zh) |
CN (1) | CN100409845C (zh) |
AT (1) | ATE267595T1 (zh) |
AU (2) | AU9393601A (zh) |
BG (1) | BG107739A (zh) |
BR (1) | BR0114410A (zh) |
CA (1) | CA2424934A1 (zh) |
DE (1) | DE60103556T3 (zh) |
DK (1) | DK1328269T5 (zh) |
EA (1) | EA005924B1 (zh) |
EE (1) | EE200300121A (zh) |
ES (1) | ES2217191T5 (zh) |
FR (1) | FR2814678B1 (zh) |
HR (1) | HRP20030249A2 (zh) |
HU (1) | HUP0302044A3 (zh) |
IL (1) | IL155236A0 (zh) |
MX (1) | MXPA03002845A (zh) |
NO (1) | NO20031521L (zh) |
NZ (1) | NZ524904A (zh) |
PL (1) | PL362833A1 (zh) |
PT (1) | PT1328269E (zh) |
SI (1) | SI1328269T2 (zh) |
SK (1) | SK4032003A3 (zh) |
TR (1) | TR200401264T4 (zh) |
WO (1) | WO2002028346A2 (zh) |
YU (1) | YU26103A (zh) |
ZA (1) | ZA200303015B (zh) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2833842B1 (fr) * | 2001-12-21 | 2004-02-13 | Aventis Pharma Sa | Compositions pharmaceutiques a base de derives d'azetidine |
CA2478183C (en) | 2002-03-12 | 2010-02-16 | Merck & Co. Inc. | Substituted amides |
WO2003082190A2 (en) | 2002-03-26 | 2003-10-09 | Merck & Co., Inc. | Spirocyclic amides as cannabinoid receptor modulators |
WO2003082191A2 (en) | 2002-03-28 | 2003-10-09 | Merck & Co., Inc. | Substituted 2,3-diphenyl pyridines |
CA2481313A1 (en) | 2002-04-12 | 2003-10-23 | Merck & Co., Inc. | Bicyclic amides |
EP1532132B1 (en) | 2002-07-29 | 2008-03-19 | F.Hoffmann-La Roche Ag | Novel benzodioxoles |
AU2003298227A1 (en) | 2003-01-02 | 2004-07-29 | F. Hoffmann-La Roche Ag | Novel cb 1 receptour inverse agonists |
RU2330035C2 (ru) | 2003-01-02 | 2008-07-27 | Ф.Хоффманн-Ля Рош Аг | Пирролилтиазолы и фармацевтическая композиция, обладающая свойством модулятора рецептора св1 |
US7329658B2 (en) * | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US20040224962A1 (en) * | 2003-05-09 | 2004-11-11 | Pfizer Inc | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
JP3939744B2 (ja) | 2003-06-11 | 2007-07-04 | メルク エンド カムパニー インコーポレーテッド | 置換3−アルキルおよび3−アルケニルアゼチジン誘導体 |
ATE390922T1 (de) | 2003-06-20 | 2008-04-15 | Hoffmann La Roche | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten |
EP1498123A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Emulsifying systems containing azetidine derivatives |
EP1498122A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Semi-solid systems containing azetidine derivatives |
WO2005020992A1 (en) * | 2003-09-02 | 2005-03-10 | Solvay Pharmaceuticals Gmbh | Novel medical use of selective cb1-receptor antagonists |
FR2861303A1 (fr) * | 2003-10-24 | 2005-04-29 | Sanofi Synthelabo | Utilisation d'un derive de pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique |
WO2005049615A1 (en) * | 2003-11-21 | 2005-06-02 | Pfizer Products Inc. | Pyrazolo`1,5-a!`1,3,5! triazin -4-one derivatives as cb1 receptor antagonists |
CA2547804A1 (en) | 2003-12-08 | 2005-06-30 | F. Hoffmann-La Roche Ag | Novel thiazole derivatives |
CA2553970A1 (en) | 2004-01-28 | 2005-08-18 | F. Hoffmann-La Roche Ag | Spiro-benzodioxoles and their use as cb1 antagonists |
CA2564986A1 (en) | 2004-05-10 | 2005-11-17 | F. Hoffmann-La Roche Ag | Pyrrole or imidazole amides for treating obesity |
US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
JP2008514718A (ja) * | 2004-09-29 | 2008-05-08 | シェーリング コーポレイション | 置換アゼチドノンおよびcb1アンタゴニストの組み合わせ |
FR2876689B1 (fr) * | 2004-10-14 | 2008-02-22 | Aventis Pharma Sa | Nouveau procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide |
JP2008517976A (ja) | 2004-10-25 | 2008-05-29 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb1カンナビノイド受容体拮抗薬及びカリウムチャンネルオープナーから成る、真性糖尿病1型、肥満及び関連症状の治療用の医薬組成物 |
AU2005298986A1 (en) | 2004-10-27 | 2006-05-04 | F. Hoffmann-La Roche Ag | New indole or benzimidazole derivatives |
ES2351348T3 (es) | 2004-11-09 | 2011-02-03 | F. Hoffmann-La Roche Ag | Derivados de la dibenzosuberona. |
RU2404164C2 (ru) | 2005-04-06 | 2010-11-20 | Ф.Хоффманн-Ля Рош Аг | Производные пиридин-3-карбоксамида в качестве обратных агонистов св1 |
US7906652B2 (en) | 2005-11-28 | 2011-03-15 | Merck Sharp & Dohme Corp. | Heterocycle-substituted 3-alkyl azetidine derivatives |
JP2009528999A (ja) * | 2006-02-21 | 2009-08-13 | アンプラ ファーマシューティカルズ インコーポレイテッド | Cb1アンタゴニストおよび逆アゴニスト |
US8247442B2 (en) | 2006-03-29 | 2012-08-21 | Purdue Pharma L.P. | Benzenesulfonamide compounds and their use |
WO2007118854A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and the use thereof |
WO2007118853A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
US7629346B2 (en) | 2006-06-19 | 2009-12-08 | Hoffmann-La Roche Inc. | Pyrazinecarboxamide derivatives as CB1 antagonists |
AR061606A1 (es) * | 2006-06-22 | 2008-09-10 | Medichem Sa | Formas solidas de rimonabant y procesos para su preparacion |
WO2008026219A2 (en) * | 2006-09-01 | 2008-03-06 | Hetero Drugs Limited | Novel polymorphs of rimonabant |
US7781593B2 (en) | 2006-09-14 | 2010-08-24 | Hoffmann-La Roche Inc. | 5-phenyl-nicotinamide derivatives |
CN101516839A (zh) * | 2006-09-25 | 2009-08-26 | 贝林格尔.英格海姆国际有限公司 | 调节cb2受体的化合物 |
DE102007002260A1 (de) | 2007-01-16 | 2008-07-31 | Sanofi-Aventis | Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms |
EP1953144A1 (en) * | 2007-01-30 | 2008-08-06 | Sandoz AG | Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide |
US8399486B2 (en) | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
WO2009040659A2 (en) | 2007-09-28 | 2009-04-02 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
KR20100098563A (ko) * | 2007-12-18 | 2010-09-07 | 사노피-아벤티스 | 아제티딘 유도체, 그의 제법 및 치료에서의 그의 적용 |
WO2010079241A1 (es) | 2009-01-12 | 2010-07-15 | Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion | Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas |
BRPI0902481B8 (pt) | 2009-07-31 | 2021-05-25 | Soc Beneficente De Senhoras Hospital Sirio Libanes | composição farmacêutica compreendendo hemopressina e seu uso. |
US8410107B2 (en) | 2010-10-15 | 2013-04-02 | Hoffmann-La Roche Inc. | N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
US8669254B2 (en) | 2010-12-15 | 2014-03-11 | Hoffman-La Roche Inc. | Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE61928B1 (en) † | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
JPH04360167A (ja) * | 1991-06-06 | 1992-12-14 | Mitsubishi Kasei Corp | 近接帯電装置 |
FR2713225B1 (fr) † | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
JPH07209959A (ja) * | 1994-01-24 | 1995-08-11 | Ricoh Co Ltd | 帯電装置 |
US5596106A (en) † | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
FR2735774B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant |
US6482927B1 (en) * | 1995-11-27 | 2002-11-19 | Millennium Pharmaceuticals, Inc. | Chimeric proteins comprising the extracellular domain of murine Ob receptor |
GB9619961D0 (en) * | 1996-09-25 | 1996-11-13 | Knoll Ag | Medical treatment |
CA2269660A1 (en) * | 1996-10-31 | 1998-05-07 | Merck & Co., Inc. | Combination therapy for the treatment of diabetes and obesity |
FR2758723B1 (fr) † | 1997-01-28 | 1999-04-23 | Sanofi Sa | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
AU8675798A (en) * | 1997-07-29 | 1999-02-22 | Silicon Genesis Corporation | Cluster tool method and apparatus using plasma immersion ion implantation |
EP0920864A1 (en) † | 1997-12-03 | 1999-06-09 | Pfizer Products Inc. | Combination therapy including a specific beta-3 agonist and an anorectic agent |
FR2783246B1 (fr) * | 1998-09-11 | 2000-11-17 | Aventis Pharma Sa | Derives d'azetidine, leur preparation et les medicaments les contenant |
KR100652994B1 (ko) † | 1998-09-11 | 2006-11-30 | 아방티 파르마 소시에테 아노님 | 아제티딘 유도체, 이의 제조방법 및 이를 함유하는 약제 |
FR2805810B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
-
2000
- 2000-10-04 FR FR0012646A patent/FR2814678B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-01 DE DE60103556T patent/DE60103556T3/de not_active Expired - Lifetime
- 2001-10-01 JP JP2002531972A patent/JP4221221B2/ja not_active Expired - Fee Related
- 2001-10-01 SI SI200130139T patent/SI1328269T2/sl unknown
- 2001-10-01 AT AT01974413T patent/ATE267595T1/de not_active IP Right Cessation
- 2001-10-01 BR BR0114410-3A patent/BR0114410A/pt not_active IP Right Cessation
- 2001-10-01 CA CA002424934A patent/CA2424934A1/fr not_active Abandoned
- 2001-10-01 EA EA200300441A patent/EA005924B1/ru not_active IP Right Cessation
- 2001-10-01 CN CNB018182682A patent/CN100409845C/zh not_active Expired - Fee Related
- 2001-10-01 EE EEP200300121A patent/EE200300121A/xx unknown
- 2001-10-01 HU HU0302044A patent/HUP0302044A3/hu unknown
- 2001-10-01 EP EP01974413A patent/EP1328269B2/fr not_active Expired - Lifetime
- 2001-10-01 PL PL01362833A patent/PL362833A1/xx not_active Application Discontinuation
- 2001-10-01 SK SK403-2003A patent/SK4032003A3/sk not_active Application Discontinuation
- 2001-10-01 ES ES01974413T patent/ES2217191T5/es not_active Expired - Lifetime
- 2001-10-01 DK DK01974413T patent/DK1328269T5/da active
- 2001-10-01 YU YU26103A patent/YU26103A/sh unknown
- 2001-10-01 PT PT01974413T patent/PT1328269E/pt unknown
- 2001-10-01 NZ NZ524904A patent/NZ524904A/en unknown
- 2001-10-01 AU AU9393601A patent/AU9393601A/xx active Pending
- 2001-10-01 KR KR10-2003-7004772A patent/KR20030036885A/ko not_active Application Discontinuation
- 2001-10-01 IL IL15523601A patent/IL155236A0/xx unknown
- 2001-10-01 MX MXPA03002845A patent/MXPA03002845A/es active IP Right Grant
- 2001-10-01 TR TR2004/01264T patent/TR200401264T4/xx unknown
- 2001-10-01 WO PCT/FR2001/003022 patent/WO2002028346A2/fr active IP Right Grant
- 2001-10-01 AU AU2001293936A patent/AU2001293936B2/en not_active Ceased
-
2003
- 2003-04-02 HR HR20030249A patent/HRP20030249A2/hr not_active Application Discontinuation
- 2003-04-03 NO NO20031521A patent/NO20031521L/no not_active Application Discontinuation
- 2003-04-16 ZA ZA200303015A patent/ZA200303015B/en unknown
- 2003-04-17 BG BG107739A patent/BG107739A/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1328269T4 (da) | Kombination af en CB1-receptorantagonist og sibutramin til behandling af fedme | |
TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
IL185871A0 (en) | N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor | |
DK1301436T3 (da) | Fremgangsmåder til syntese af et oxidationsmiddel samt dets anvendelse | |
AU3652102A (en) | Compounds and their uses | |
DK1339678T3 (da) | Selektive agonister til EP4-receptor til behandling af osteoporose | |
WO2002064125A3 (en) | Use of a farnesoid x receptor antagonist for treating hyperlipidemia | |
DK1383742T3 (da) | Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater | |
DK1441761T3 (da) | Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr | |
SE0302361D0 (sv) | Inhibering av upptagning av monoamin | |
DK1177191T3 (da) | Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer | |
DK1420789T3 (da) | Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling | |
DK1373232T3 (da) | Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner | |
MXPA03006970A (es) | Nuevo uso de iloperidona. | |
ATE328595T1 (de) | Carvedilolpolymorph | |
DK1366033T3 (da) | Kemiske forbindelser | |
DE50212676D1 (de) | Exopolysaccharidproduktion | |
DK1377294T3 (da) | Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination | |
IT1317742B1 (it) | Composizioni a rilascio controllato di metamizolo e tramadolo. | |
BR8103537Y1 (pt) | aparelho alongador lombo-sacro flutuante. |